BL
Bluebird Bio
BLUE·NASDAQSomerville MAFounded 2010600 employees
Small CapbiotechPublicRare DiseaseHematology
Platform: LV Gene
Market Cap
$0.3B
All Drugs
2
Clinical Trials
4
Failed / Terminated
2
FDA Approved
1
Stock Price & Catalysts (BLUE)
Loading BLUE stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| BLU-5648 | BLU-5648 | Approved | 2 | WRN | PTSD | ||
| Semarapivir | BLU-6877 | Phase 2 | 2 | FXIa | ThymomaET |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)